WA
ABBV icon

Waddell & Associates’s AbbVie ABBV Stock Holding History

Waddell & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$928K Buy
3,688
+332
+10% +$71.4K 0.05% 144
2026
Q1 		$730K Buy
3,356
+101
+3% +$22.4K 0.04% 151
2025
Q4 		$744K Sell
3,255
-65
-2% -$14.8K 0.05% 118
2025
Q3 		$769K Buy
3,320
+1,360
+69% +$277K 0.07% 89
2025
Q2 		$364K Buy
1,960
+7
+0.4% +$1.3K 0.04% 145
2025
Q1 		$409K Sell
1,953
-10
-0.5% -$1.94K 0.05% 100
2024
Q4 		$349K Sell
1,963
-59
-3% -$10.8K 0.04% 112
2024
Q3 		$399K Buy
2,022
+67
+3% +$12.5K 0.05% 95
2024
Q2 		$335K Buy
1,955
+75
+4% +$12.4K 0.04% 98
2024
Q1 		$342K Sell
1,880
-1,988
-51% -$343K 0.05% 97
2023
Q4 		$597K Sell
3,868
-239
-6% -$34.8K 0.08% 69
2023
Q3 		$612K Sell
4,107
-99
-2% -$14.5K 0.09% 68
2023
Q2 		$567K Sell
4,206
-340
-7% -$49.9K 0.08% 69
2023
Q1 		$724K Sell
4,546
-1,699
-27% -$260K 0.11% 60
2022
Q4 		$1.01M Buy
6,245
+620
+11% +$95.1K 0.17% 45
2022
Q3 		$755K Sell
5,625
-89
-2% -$12.8K 0.15% 49
2022
Q2 		$875K Buy
5,714
+1,935
+51% +$296K 0.18% 46
2022
Q1 		$613K Sell
3,779
-1,140
-23% -$166K 0.1% 57
2021
Q4 		$666K Buy
4,919
+53
+1% +$6.26K 0.11% 56
2021
Q3 		$525K Buy
4,866
+200
+4% +$22.9K 0.09% 61
2021
Q2 		$526 Buy
+4,666
New +$526K 0.08% 60

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Waddell & Associates's ABBV Position: Q2 2026 in Review

Waddell & Associates increased its AbbVie (ABBV) stake by 9.9% in Q2 2026, buying an estimated $71.4K and bringing the position to 3,688 shares worth $928K. The position accounts for 0.05% of the portfolio, ranked #144.

Waddell & Associates first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.01M in Q4 2022. 1,656 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Waddell & Associates held 3,688 shares of AbbVie worth $928K as of Q2 2026.
  • Waddell & Associates bought 332 AbbVie shares in Q2 2026, an estimated $71.4K.
  • AbbVie made up 0.05% of Waddell & Associates's portfolio in Q2 2026, its #144 holding.
  • Waddell & Associates first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • Waddell & Associates's AbbVie position peaked at $1.01M in Q4 2022.
  • 1,656 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.